TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
TELO · 6M
—
O--
H--
L--
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
SMA 20SMA 50
—Context
- Move across the chart.
Events in view
| Date | Kind | Event | Source |
|---|---|---|---|
| 2026-11-06 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-11-05 | filing | 424B3 (prospectus) | SEC EDGAR |
| 2026-10-27 | filing | S-3 (shelf registration) | SEC EDGAR |
| 2026-10-06 | filing | 8-K: material agreement; unregistered sale of equity (dilution); Reg FD disclosure | SEC EDGAR |
| 2026-09-17 | filing | 8-K: Reg FD disclosure | SEC EDGAR |
| 2026-09-16 | filing | 8-K: shareholder vote | SEC EDGAR |
| 2026-09-14 | filing | 8-K: Reg FD disclosure | SEC EDGAR |
| 2026-08-19 | filing | DEFA14A (proxy material) | SEC EDGAR |
| 2026-08-13 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-08-10 | filing | 8-K: Reg FD disclosure | SEC EDGAR |
| 2026-07-28 | filing | DEF 14A (proxy statement) | SEC EDGAR |
| 2026-06-15 | filing | 8-K: Reg FD disclosure | SEC EDGAR |
| 2026-06-08 | filing | 8-K: officer / director change | SEC EDGAR |
| 2026-05-20 | filing | 8-K: Reg FD disclosure | SEC EDGAR |
| 2026-05-14 | filing | 10-Q (quarterly report) | SEC EDGAR |
Performance
1D
+4.02%
5D
-32.00%
1M
-45.91%
3M
-46.40%
6M
-51.63%
YTD
-55.26%
1Y
-58.10%
2Y
-86.42%
3Y
--
5Y
--
MAX
-93.44%
Period
-55.60%
High
1.58
Low
0.5450
Ann Vol
51.16%
Sharpe
-1.45
Max DD
-59.72%
ATR (14)
0.0913